Literature DB >> 28979560

A case study of likely wild-type cardiac transthyretin amyloidosis causing rapid deterioration.

Thomas Davies1, Aarash Saleh1, Gerry Coghlan2, Carol Whelan2,3, Banwari Agarwal1.   

Abstract

We present the case of an 88-year-old gentleman who presented to hospital septic with bilateral leg cellulitis, pulmonary oedema and hypotension. He had no history of heart disease but had had bilateral carpal tunnel releases. His condition deteriorated with refractory hypotension in spite of fluid filling, inotropic and vasopressor support. His echocardiogram showed an infiltrative cardiomyopathy with a speckled myocardium, severe concentric left and right ventricular increased wall thickness, diastolic dysfunction, biatrial dilatation and restrictive physiology in keeping with cardiac amyloidosis. He developed atrial fibrillation and worsening respiratory failure due to fluid overload and was intubated and ventilated but continued to decline and passed away. The degree of heart failure in the absence of ischaemia, the patient's advanced age, echocardiographic findings and past history of carpal tunnel syndrome in a male are strongly indicative of a diagnosis of wild-type cardiac transthyretin amyloidosis. We discuss the key features and intensive care management of this disease.

Entities:  

Keywords:  Amyloidosis; critical care; heart failure; transthyretin

Year:  2016        PMID: 28979560      PMCID: PMC5606417          DOI: 10.1177/1751143716682263

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  26 in total

Review 1.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelisa
Journal:  Eur J Echocardiogr       Date:  2009-03

Review 2.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

3.  Association between inotrope treatment and 90-day mortality in patients with septic shock.

Authors:  E Wilkman; K-M Kaukonen; V Pettilä; A Kuitunen; M Varpula
Journal:  Acta Anaesthesiol Scand       Date:  2013-01-08       Impact factor: 2.105

4.  Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure.

Authors:  John T Parissis; Fotios Panou; Dimitrios Farmakis; Stamatis Adamopoulos; Gerasimos Filippatos; Ioannis Paraskevaidis; Koula Venetsanou; John Lekakis; Dimitrios Th Kremastinos
Journal:  Am J Cardiol       Date:  2005-08-01       Impact factor: 2.778

5.  Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.

Authors:  Belinda Ng; Lawreen H Connors; Ravin Davidoff; Martha Skinner; Rodney H Falk
Journal:  Arch Intern Med       Date:  2005-06-27

6.  Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.

Authors:  David F Hutt; Anne-Marie Quigley; Joanne Page; Margaret L Hall; Maria Burniston; Dorothea Gopaul; Thirusha Lane; Carol J Whelan; Helen J Lachmann; Julian D Gillmore; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-06-16       Impact factor: 6.875

Review 7.  Diastolic heart failure in anaesthesia and critical care.

Authors:  R Pirracchio; B Cholley; S De Hert; A Cohen Solal; A Mebazaa
Journal:  Br J Anaesth       Date:  2007-04-28       Impact factor: 9.166

8.  Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty.

Authors:  Alberto Dominguez-Rodriguez; Sima Samimi-Fard; Martin J Garcia-Gonzalez; Pedro Abreu-Gonzalez
Journal:  Int J Cardiol       Date:  2007-07-23       Impact factor: 4.164

9.  Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations.

Authors:  Per Westermark; Joakim Bergström; Alan Solomon; Charles Murphy; Knut Sletten
Journal:  Amyloid       Date:  2003-08       Impact factor: 7.141

Review 10.  The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.

Authors:  G Merlini; P Westermark
Journal:  J Intern Med       Date:  2004-02       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.